Silverarc Capital Management, LLC I Teos Therapeutics, Inc. Transaction History

Silverarc Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$16.57 - $35.1 $2.3 Million - $4.87 Million	-138,843 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$31.92 - $47.45 $26,717 - $39,715	837 Added 0.61%	138,843 $4.47 Million
Q4 2021 Feb 14, 2022	BUY	$26.23 - $47.86 $552,797 - $1.01 Million	21,075 Added 18.02%	138,006 $6.43 Million
Q3 2021 Nov 15, 2021	BUY	$23.91 - $29.58 $990,352 - $1.23 Million	41,420 Added 54.85%	116,931 $3.16 Million
Q2 2021 Aug 16, 2021	BUY	$17.9 - $36.1 $1.35 Million - $2.73 Million	75,511 New	75,511 $1.94 Million

169

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $285M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.